Impact of in-house specialty pharmacy on access to novel androgen axis inhibitors in men with advanced prostate cancer.

Authors

• William Kelly

Publication/Presentation Date

10-2019

Volume

37

Issue

27

Published In/Presented At

DOI: 10.1200/JCO.2019.37.27_suppl.132

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article